HSBC upgraded Moderna (MRNA) to Hold from Reduce with a $58 price target Don't Miss our Black Friday Offers:Discover the latest stocks ...

Piper Sandler lowered the firm’s price target on Moderna (MRNA) to $69 from $115 and keeps an Overweight rating on the shares. The firm notes ...

Shares of vaccine makers such as Moderna (MRNA) and Pfizer (PFE) have plunged on news that president-elect Donald Trump has ...

U.S. stocks were mixed after the close on Monday, as gains in the Consumer Goods, Telecoms and Oil & Gas sectors led shares higher while losses in the Healthcare, Industrials and Consumer Services ...

Most U.S. stocks ticked higher to recover some of their sharp slide from last week. The S&P 500 rose 0.4% Monday for its first gain in three days. The Dow Jones Industrial Average slipped 0.1%, and ...

“ [Trump’s plans] will come at the expense of potentially larger budget deficits, potentially larger debt and there is also ...

Moderna’s ( NASDAQ: MRNA) steep fall on Friday after President-elect Donald Trump selected vaccine critic Robert F. Kennedy Jr. to head the U.S. Department of Health and Human Services makes a good ...

Shares in biotech firm Moderna (NASDAQ:MRNA) rose more than 4% Monday after HSBC raised its rating on the stock from Hold to ...

In light of Donald Trump’s election, Europe needs to lead in the climate action and emissions reduction, according to the German Secretary and Special Envoy for International Climate Action.

Two separate shootings disrupted a "second line" parade in New Orleans' St Roch neighborhood, claiming the lives of two individuals and leaving nine others injured. The incidents, occurring 45 ...